John Dicey goes on to say, “Given the ongoing controversy over vaping, which doesn’t appear to be dying down anytime soon, these results should give Public Health England and the Irish Health Service Executive (HSE) the confidence to provide Allen Carr’s Easyway as a nicotine-free, entirely safe, and popular alternative to the methods currently available.”
The results of the Irish trial showed that Allen Carr’s Easyway quit rates were always superior to Quit.ie, consistently achieving higher quit rates at 1, 3, 6 and 12 months (almost twice as good) and the results of the London trial indicate a 6 month success rate of 19% for Allen Carr’s Easyway vs 15% for the NHS Gold Standard Service.
These results should pave the way for this drug-free, perfectly safe, quick and easy method to be made available via the NHS, the Irish Health Service, and health services in the 50 countries where we operate.” “Nicotine patches, gum, and other nicotine products cost the taxpayer around £30 million*** a year in the UK alone and an estimated £900 million worth of nicotine has been prescribed in the UK over the past 20 years. That said, even in these limiting settings we’re delighted that the method was found to be at least as effective or more effective when compared to the drug and nicotine-based programmes currently provided within the NHS, Local Health Authorities, and the health departments of governments all over the world. There is no doubt that being a spoken method, rather than a pill, potion, or patch, makes a clinical trial’s assessment of the method limited and hugely underestimates its success rate in ‘real world’ conditions. “This is a landmark day as, for the first time, the programme’s performance is presented in not just one, but now two clinical trials. John Dicey, Global CEO of Allen Carr’s Easyway, comments: “Allen Carr is a hugely underused treatment method which has great potential to help achieve our ambitious targets in tobacco control.”
Tobacco Free Research Institute Ireland (TFRI) Director General Prof Luke Clancy said: Tob Control 2019 28:414–419.), which indicated that the method was nearly twice as effective as the existing Quit.ie service**. This was initiated by the Irish Government and recently published in the British Medical Journal’s “Tobacco Control” (Keogan S, Li S, Clancy L. The findings of this RCT supplement another recent peer-reviewed, independent study that also proves the effectiveness of the Allen Carr’s Easyway method. “These findings offer compelling support for the efficacy of the Allen Carr’s Easyway method for smoking cessation.” Professor Daniel Frings, from the research team, comments: As such, it may offer a viable cost-effective additional treatment option in public/funded healthcare settings. The study, published today, concludes that evaluating the effectiveness of the ACE method is important as it offers a drug-free method of smoking cessation that can be delivered in group therapy sessions. Man whose arrest led to ‘separate but equal’ is pardoned